Qiaoqiao Han

998 total citations · 1 hit paper
37 papers, 698 citations indexed

About

Qiaoqiao Han is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Qiaoqiao Han has authored 37 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Qiaoqiao Han's work include Pain Mechanisms and Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Qiaoqiao Han is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Qiaoqiao Han collaborates with scholars based in China, United States and Croatia. Qiaoqiao Han's co-authors include Yingmin Kuang, Huixin Yang, Yuqian Li, Zihan Yi, Qiang Zou, Zhe Yang, Yuerong Zhang, Yong‐Xiang Wang, Long Chen and Yuechun Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Immunity and Nature Cell Biology.

In The Last Decade

Qiaoqiao Han

36 papers receiving 692 citations

Hit Papers

Lactate modulates RNA splicing to promote CTLA-4 expressi... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaoqiao Han China 15 361 263 128 90 75 37 698
Saeid Afshar Iran 20 448 1.2× 322 1.2× 81 0.6× 166 1.8× 120 1.6× 73 954
Ming Yao China 16 370 1.0× 146 0.6× 148 1.2× 116 1.3× 44 0.6× 47 787
Juntang Li China 18 338 0.9× 196 0.7× 98 0.8× 122 1.4× 65 0.9× 35 751
Xuexiang Wang China 15 361 1.0× 137 0.5× 160 1.3× 177 2.0× 82 1.1× 40 800
Ali Akbar Samadani Iran 21 548 1.5× 239 0.9× 113 0.9× 173 1.9× 137 1.8× 61 948
Guie Xie China 14 284 0.8× 146 0.6× 87 0.7× 76 0.8× 38 0.5× 29 612
Xiaoqing Zhu China 17 389 1.1× 176 0.7× 231 1.8× 127 1.4× 55 0.7× 54 757
Kyu-Sil Choi South Korea 11 383 1.1× 106 0.4× 91 0.7× 83 0.9× 51 0.7× 13 786

Countries citing papers authored by Qiaoqiao Han

Since Specialization
Citations

This map shows the geographic impact of Qiaoqiao Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaoqiao Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaoqiao Han more than expected).

Fields of papers citing papers by Qiaoqiao Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaoqiao Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaoqiao Han. The network helps show where Qiaoqiao Han may publish in the future.

Co-authorship network of co-authors of Qiaoqiao Han

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaoqiao Han. A scholar is included among the top collaborators of Qiaoqiao Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaoqiao Han. Qiaoqiao Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Miao, Xiaolei Zhou, Zhenzhen Li, et al.. (2025). Decitabine regulates the resistance of HCC to sorafenib through demethylation. Clinical Epigenetics. 17(1). 120–120.
3.
Ding, Rui, Zhilin Hu, Yu Dong, et al.. (2024). Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity. 57(3). 528–540.e6. 64 indexed citations breakdown →
4.
Zhang, Zhen, Xinkui Liu, Chu Chu, et al.. (2024). MIR937 amplification potentiates ovarian cancer progression by attenuating FBXO16 inhibition on ULK1-mediated autophagy. Cell Death and Disease. 15(10). 735–735. 2 indexed citations
5.
Han, Qiaoqiao, Shuang Wang, Xu Cheng, et al.. (2024). Flexible polyurethane films based on porous Carbon/Ni composite for electromagnetic absorber, photothermal deicing, and sensor. Composites Part A Applied Science and Manufacturing. 186. 108414–108414. 6 indexed citations
6.
Hu, Zhilin, Xiaoyan Yu, Rui Ding, et al.. (2023). Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. Journal of Clinical Investigation. 133(7). 58 indexed citations
7.
Wan, Jie, Cheng Cheng, Jiajia Hu, et al.. (2023). De novo NAD+ synthesis contributes to CD8+ T cell metabolic fitness and antitumor function. Cell Reports. 42(12). 113518–113518. 12 indexed citations
8.
Han, Qiaoqiao, Shuang Wang, Xu Cheng, et al.. (2023). Self-healing polyurethane coating based on porous carbon/Ni hybrid composites for electromagnetic wave absorption. Composites Part A Applied Science and Manufacturing. 175. 107830–107830. 13 indexed citations
9.
Wang, Aiting, Haiyan Huang, Jianhong Shi, et al.. (2023). USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. Journal of Clinical Investigation. 133(23). 28 indexed citations
10.
Zhang, Yuerong, Rujuan Bao, Haiyan Huang, et al.. (2023). Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses. Cell Metabolism. 35(12). 2107–2118.e6. 30 indexed citations
11.
Han, Qiaoqiao, Miao Zhang, Tao You, et al.. (2022). Research advances in treatment methods and drug development for rare diseases. Frontiers in Pharmacology. 13. 971541–971541. 9 indexed citations
12.
Han, Qiaoqiao, Xinyan Li, & Yong‐Xiang Wang. (2022). Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation. International Immunopharmacology. 109. 108920–108920. 8 indexed citations
13.
Liu, Hao, et al.. (2021). Microglial M2 Polarization Mediated the Neuroprotective Effect of Morroniside in Transient MCAO-Induced Mice. Frontiers in Pharmacology. 12. 784329–784329. 12 indexed citations
14.
Han, Qiaoqiao, Mengyan Deng, Hao Liu, et al.. (2021). Cynandione A and PHA-543613 inhibit inflammation and stimulate macrophageal IL-10 expression following α7 nAChR activation. Biochemical Pharmacology. 190. 114600–114600. 9 indexed citations
15.
Deng, Mengyan, Khalil Ali Ahmad, Qiaoqiao Han, et al.. (2021). Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway. Biochemical Pharmacology. 192. 114727–114727. 19 indexed citations
16.
Han, Qiaoqiao, Min Yin, Ziying Wang, et al.. (2021). Cynandione A Alleviates Neuropathic Pain Through α7-nAChR-Dependent IL-10/β-Endorphin Signaling Complexes. Frontiers in Pharmacology. 11. 614450–614450. 13 indexed citations
17.
Li, Xinyan, et al.. (2018). Regulation of Gli2 stability by deubiquitinase OTUB2. Biochemical and Biophysical Research Communications. 505(1). 113–118. 13 indexed citations
18.
Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma. Journal of Cancer. 8(4). 665–673. 35 indexed citations
19.
Chen, Long, Chunhua Zhang, Yanling Wang, et al.. (2017). Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing. Molecular Medicine Reports. 16(2). 1900–1910. 6 indexed citations
20.
Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3. Oncotarget. 8(65). 109043–109060. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026